University Health Network: Toronto General Hospital
Toronto, Ontario, M5G 2C4, Canada
NCT Number: NCT02090660
This study will determine the feasibility of the novel Indocyanine Green (ICG) fluorescence localization technique with a Laser fluorescence thoracoscope system.
The primary objective of this study is to prove the validity and safety of our novel fluorescent localization method with utilized ICG and novel near infra-red fluorescence videoscope system.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2
Toronto, Ontario, M5G 2C4, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Within 4 hours of ICG injection
University Health Network, Toronto
Other
Feasibility of a Novel Minimally Invasive Technique for Localization of Pulmonary Nodules Using the Spy Thoracoscope System
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04465214
Colon Cancer, Colonic Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT04354246
Adnexal Diseases, Advanced Cancer
Sarasota, Florida, United States
View Trial DetailsNCT06389981
Lung Cancer, Lung Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT05794607
Lung Cancer, Lung Diseases
Istanbul, Turkey (Türkiye)
View Trial Details